Medical Director, Adult Stem Cell Transplant Program; Professor, Oregon Health and Science University
Hematology
Dr. Richard T. Maziarz, MD
|
|
Give Review
Richard Maziarz works in the field of Hematology. He attended Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He has 4 awards "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification" and "Portland Monthly Magazine". Richard Maziarz is also a published doctor. He has 101 paper published. The most recent paper is: Allogeneic hematopoietic cell transplantation for patients with mixed phenotype acute leukemia. He accepts all Medicare patients.
Publications
- Allogeneic hematopoietic cell transplantation for patients with mixed phenotype Acute leukemia.
- Pre-transplant comorbidity burden and post-transplant Chronic graft-versus-host disease.
- Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and Immune reconstitution analysis.
- Solution-Phase Crosstalk and Regulatory Interactions Between Multipotent Adult Progenitor Cells and Peripheral Blood Mononuclear Cells.
- Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic...
- Nonmyeloablative allogeneic hematopoietic stem Cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body ...
- Comparison of Outcomes of Allogeneic Transplantation for CML with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan or TBI.
- Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary Syndrome.
- Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Synd...
- Long-Term Survival after Transplantation of Unrelated Donor Peripheral Blood or Bone Marrow Hematopoietic Cells for Hematologic Malignancy.
- Outcomes of Human Leukocyte Antigen-Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative Versus Reduced-Intensity Co...
- Pre-transplant comorbidities predict severity of Acute graft-versus-host disease and subsequent mortality.
- Avascular necrosis of bone after allogeneic hematopoietic Cell transplantation in children and adolescents.
- Validation and refinement of the Disease risk index for allogeneic stem cell transplantation: a study from the CIBMTR.
- Outcomes of hematopoietic cell transplantation for diffuse large B cell Lymphoma transformed from follicular Lymphoma.
- Improved outcome with busulfan, melphalan and thiotepa conditioning in autologous hematopoietic stem cell transplant for relapsed/refractory Hodgkin Lymphoma.
- Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations.
- Induction Bortezomib in AL Amyloidosis Followed By High Dose Melphalan and Autologous Stem Cell Transplantation: A Single Institution Retrospective Study.
- Adult adherent stromal cells in the management of Graft-versus-host disease.
- Treosulfan, Fludarabine, and 2-Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute ...
- Reduced-intensity hematopoietic Cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow tran...
- A pilot study of the efficacy and safety of empiric daptomycin therapy in oncology patients with fever and severe Neutropenia.
- Does Total Body Irradiation Conditioning Improve Outcomes of Myeloablative Human Leukocyte Antigen-Identical Sibling Transplantations for Chronic Lymphocytic Leukemia?
- Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation...
- Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34(+) hematopoietic progenitor Cells in patients ≥60 and <60 years of ag...
- Human multipotent adult progenitor Cells transcriptionally regulate fucosyltransferase VII.
- Fludarabine and 2-Gy TBI is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial.
- Better Leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared to TBI.
- Autologous haematopoietic cell transplantation for non-Hodgkin Lymphoma with secondary CNS involvement.
- Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for Lymphoma and mye...
- Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic Syndromes (MDS).
- Emergence of Cunninghamella As a Pathogenic Invasive Mold Infection in Allogeneic Transplant Recipients.
- Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma.
- Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of...
- Unrelated donor allogeneic transplantation after failure of autologous transplantation for Acute myeloid leukemia: a study from the cibmtr.
- Graft-versus-host disease and Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.
- Hematopoietic stem Cell transplantation for myelofibrosis: where are we now?
- Autologous and allogeneic transplantation for burkitt Lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transpl...
- Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?
- Plerixafor Plus Granulocyte Colony-Stimulating Factor Improves the Mobilization of Hematopoietic Stem Cells in Patients with Non-Hodgkin Lymphoma and Low Circulating P...
- Salvage Second Hematopoietic Cell Transplantation in Myeloma.
- Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative.
- Clinical experience with a simple algorithm for plerixafor utilization in autologous stem Cell mobilization.
- The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: A Health Care Resource and Infrastructure Assessment.
- Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic Cell transplantation for advanced hematologic malignancies.
- Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared to children and older adults with Acute myeloid leukemia.
- Classifying Cytogenetics in Patients with AML in Complete Remission Undergoing Allogeneic Transplantation: A CIBMTR Study.
- Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast Cancer following negative trial results.
- Hematopoietic stem Cell transplantation and implications for Cell therapy reimbursement.
- Novel H1N1 influenza in hematopoietic stem Cell transplantation recipients: two centers' experiences.
- Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic Cell transplantation for high-risk hematologic malignancies.
- Informal caregiving in Hematopoietic Blood and Marrow Transplant patients.
- Pregnancy after hematopoietic Cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Resear...
- Comparison of short-term response and long-term outcomes after initial Systemic treatment of chronic graft-versus-host disease.
- MSCs in hematopoietic Cell transplantation.
- Transplanted CD34(+) Cell Dose Is Associated with Long-Term Platelet Count Recovery following Autologous Peripheral Blood Stem Cell Transplant in Patients with Non-Hod...
- Control of plasma uric acid in adults at risk for tumor Lysis Syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared wit...
- Hematopoietic stem-cell transplantation for Acute leukemia in relapse or primary induction failure.
- Second unrelated donor hematopoietic cell transplantation for primary Graft failure.
- Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with Acute myeloid leukemia.
- Allogeneic hematopoietic cell transplant for prolymphocytic Leukemia.
- Response to Letter from Demetrios S. Theodoropoulos, MD, DSc.
- Transplantation for CML: 2010.
- Allogeneic transplantation for therapy-related myelodysplastic syndrome and Acute myeloid leukemia.
- Outcome of transplantation for myelofibrosis.
- Outcomes of hematologic malignancies after unrelated donor hematopoietic Cell transplantation according to place of residence.
- Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem Cell transplant recipients.
- A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell Lymphoma: a report from the CIBMTR.
- Impending challenges in the hematopoietic stem Cell transplantation physician workforce.
- Race and socioeconomic status influence outcomes of unrelated donor hematopoietic Cell transplantation.
- Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin Lymphoma: results from the pleri...
- Evaluation of mycophenolate mofetil for initial treatment of Chronic graft-versus-host disease.
- Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative alloGrafting.
- TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.
- Clinical scale expanded adult pluripotent stem cells prevent Graft-versus-host disease.
- Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin Lymphoma.
- Risk factors for Acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
- Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic Cell transplantation following nonmyeloablative conditioning for ...
- Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid Leukemia.
- Five-year follow-up of patients with advanced chronic lymphocytic Leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
- Second autologous stem cell transplantation for relapsed Lymphoma after a prior autologous transplant.
- Unrelated donor transplants in adults with Philadelphia-negative Acute lymphoblastic leukemia in first complete remission.
- Hematopoietic Cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloab...
- Who with chronic myelogenous Leukemia to transplant in the era of tyrosine kinase inhibitors?
- Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's Lymphoma.
- Extended mycophenolate mofetil and shortened cyclosporine failed to reduce Graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloab...
- Drug resistance in B-cell chronic lymphocytic Leukemia: predictable by in vitro evaluation with a multiparameter flow cytometric cytotoxicity assay.
- Factors associated with outcomes in allogeneic hematopoietic Cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic Cell tran...
- Philadelphia chromosome-positive Acute lymphoblastic leukemia: impact of imatinib treatment on remission induction and allogeneic stem cell transplantation.
- Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear Cell transplantation after nonmyeloablative conditioning: the effect of po...
- Stem cell transplantation in patients with chronic myelogenous Leukemia: when should it be used?
- Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for Acute myelogenous leukemia in first rem...
- Treatment for Acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
- Explaining family caregiver role strain following autologous blood and marrow transplantation.
- Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem Cells and hematopoietic stem Cells in hematologic malignancy patients.
- In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic Leukemia.
- Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell Lymphoma.
- Effect of up-front daclizumab when combined with steroids for the treatment of Acute graft-versus-host disease: results of a randomized trial.
- CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in Acute graft-versus-host disease.
- Pure red Cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation.
Schools
Harvard Medical School
University Hospital Cleveland
Brigham and Women39s Hospital
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Portland Monthly Magazine
Education
-
Brigham and Women's Hospital -
Harvard Medical School
Drug Facts
| NPI NUMBER | 1275548760 | |
| NPPES Provider LastName | MAZIARZ | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 972393011 | |
| NPPES Provider State | OR | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 109.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275548760 |
| Last Name Of The Provider | MAZIARZ |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
Dr. Gerald M. Segal, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert C. Lufkin, DO |
|
|
Dr. Brendan D. Curti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Renee C. Prins, MD |
|
|
Dr. John E. Godwin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shiuh-Wen Luoh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gina Vaccaro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alison K. Conlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas G. Deloughery, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Guang Fan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Raish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason C. Mann, MD |
|
|
Dr. Karen R. Macdonell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason Schallheim, MD |
|
|
Dr. Ying Pei, MD |
|
|
Dr. Kathleen A. Kemmer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward W. Soo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David C. Calverley, MD
This Doctor is OpenDoctor Recommended.
|